Form 8-K - Current report:
SEC Accession No. 0001104659-26-018314
Filing Date
2026-02-23
Accepted
2026-02-23 06:46:27
Documents
17
Period of Report
2026-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm267044d1_8k.htm   iXBRL 8-K 57811
2 EXHIBIT 2.1 tm267044d1_ex2-1.htm EX-2.1 747751
3 EXHIBIT 10.1 tm267044d1_ex10-1.htm EX-10.1 85199
4 EXHIBIT 99.1 tm267044d1_ex99-1.htm EX-99.1 26559
8 GRAPHIC tm267044d1_ex99-1img01.jpg GRAPHIC 9486
9 GRAPHIC tm267044d1_ex99-1img02.jpg GRAPHIC 7046
  Complete submission text file 0001104659-26-018314.txt   1310881

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gild-20260222.xsd EX-101.SCH 3008
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20260222_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20260222_pre.xml EX-101.PRE 22354
20 EXTRACTED XBRL INSTANCE DOCUMENT tm267044d1_8k_htm.xml XML 3092
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 26662019
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)